Enhanced Crystallisation Control Improves Polymorph Screening

Format: Video

This content is provided by Genevac, and any views and opinions expressed do not necessarily reflect those of www.outsourcing-pharma.com


Genevac announces eXalt - an exciting new non-destructive technology that enables a wide range of solvents and multiple actives to be evaporated all at the same slow rate, and under the same conditions, giving the user unprecedented control of crystallisation processes.

eXalt has found application in labs that perform tasks including first time crystallisation of amorphous forms, recrystallisation of samples which have only a few known forms, removing a hydrate, solvent screening studies to find the most suitable conditions to take forward in development, high throughput co-crystallisation screens and studies to confirm stable isoforms. 

Supplier info centre